Koc, E. Et Al. 2022. Real-world experience of ocrelizumab in MS in the Turkish population: A single-center study. EUROPEAN JOURNAL OF NEUROLOGY , 792.

Koc, E., Saridas, F., Ceylan, D., Turan, O., & Ozkaya, G., (2022). Real-world experience of ocrelizumab in MS in the Turkish population: A single-center study. EUROPEAN JOURNAL OF NEUROLOGY , 792.

Koc, E. Et Al. "Real-world experience of ocrelizumab in MS in the Turkish population: A single-center study," EUROPEAN JOURNAL OF NEUROLOGY , 792, 2022

Koc, E. Et Al. "Real-world experience of ocrelizumab in MS in the Turkish population: A single-center study." EUROPEAN JOURNAL OF NEUROLOGY , pp.792, 2022

Koc, E. Et Al. (2022) . "Real-world experience of ocrelizumab in MS in the Turkish population: A single-center study." EUROPEAN JOURNAL OF NEUROLOGY , p.792.

@article{article, author={E. Koc Et Al. }, title={Real-world experience of ocrelizumab in MS in the Turkish population: A single-center study}, journal={EUROPEAN JOURNAL OF NEUROLOGY}, year=2022, pages={792} }